Can Dapagliflozin be taken long-term?

Dapagliflozin (Dapagliflozin) is a sodium glucose co-transporter 2 (SGLT2) inhibitor, mainly used to treat 2 type diabetes. There are some important considerations to note regarding the long-term use of dapagliflozin.

Research suggests that dapagliflozin may be a long-term treatment option for diabetes. Multiple clinical trials and studies have confirmed that dapagliflozin can effectively lower blood sugar levels, improve insulin resistance, and lead to weight loss in some patients. However, you need to pay attention to the following aspects when using it for a long time:

1.Sustainability of effect: Whether the efficacy of dapagliflozin is sustained during long-term use still requires further research to confirm. Although good glycemic control may be achieved initially, individual responses may vary over time.

2.Safety: The long-term safety of dapagliflozin is an important consideration. Although clinical trials and practical applications have shown good tolerability, some adverse reactions such as urinary tract infection, ketoacidosis, etc. may increase during long-term use. Therefore, doctors conduct regular health monitoring to ensure patient safety.

3.Renal function monitoring: Dapagliflozin is mainly excreted through the kidneys, so during long-term use, renal function may need to be monitored regularly. Doctors will pay more attention to this in patients who are at risk for kidney damage.

4.Individual differences: Every patient’s situation is unique, including type of diabetes, age, health status, etc. Therefore, the suitability of dapagliflozin for long-term use should be determined on a case-by-case basis for each patient.

Dapagliflozin has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The domestic price is relatively cheap. Please consult the local hospital pharmacy or medical insurance bureau for specific prices and reimbursement policies.